Patentability and maximum protection of intellectual property in proteomics and genomics¹

Author： Warburg Richard J Wellman Arthur Buck Todd B Ligler Schoenhard Amy

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.4, Iss.1, 2003-01, pp. : 81-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Technology: methodologies in genomics and proteomics

By Jon T. John M. Chris M.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 85-88

Adis International

Access to resources Recommend Favorite

Genomics and Proteomics of Nucleoside Transporters

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-01 ,pp. : 281-287

Bentham Science Publishers

Access to resources Recommend Favorite

NIH data and resource sharing, data release and intellectual property policies for genomics community resource projects

By Driscoll Claire T

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 1, 2005-01 ,pp. : 1-8

Informa Healthcare

Access to resources Recommend Favorite

Intellectual Property Right Protection for Pharmaceuticals in Developing Countries: A Case Study of Administrative Protection in China

By Wang Y.R. Ji L. Lin Y.A.

Pharmaceutical Development and Regulation, Vol. 1, Iss. 4, 2003-01 ,pp. : 277-282

Adis International

Access to resources Recommend Favorite

Companies Applying Genomics and Proteomics to Cancer

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 1, 2003-01 ,pp. : 60-63

Adis International

Access to resources Recommend Favorite